MedTrace Logo

Mesenteric Infiltration in Ovarian Cancer

NCT06331130 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2025-03-12

No results posted yet for this study

Summary

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.

Conditions

  • Ovary Cancer

Interventions

DIAGNOSTIC_TEST

Computed Tomography

Computed Tomography done according to Clinical Practice to assess mesenteric involvment

Sponsors & Collaborators

  • Danube University Krems

    collaborator OTHER

  • Institut du Cancer de Montpellier - Val d'Aurelle

    collaborator OTHER

  • Ente Ospedaliero Cantonale, Ticino, Switzerland

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Camilla Panico, Dr · Fondazione Policlinico Universitario A. Gemelli, IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06331130 on ClinicalTrials.gov